EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of
ENDRA Life Sciences Inc.
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 16, 2023 on the consolidated financial statements of ENDRA Life Sciences Inc. and its subsidiaries, and the reference to our firm under the heading “Experts” in the prospectus included in this Registration Statement on Form S-3. Our report includes an explanatory paragraph expressing substantial doubt regarding the Company’s ability to continue as a going concern.
/s/ RBSM LLP
New York, New York
February 14, 2024
